Daily Stock List
Oromin Explorations Ltd. (OLEPF)
FeedBlitz and SmallCapVoice reported previously on Oromin Explorations Ltd. (OLEPF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Oromin Explorations Ltd. is a resource company whose shares trade on the OTC Bulletin Board. The Company focuses on exploring the OJVG Gold project in Senegal, West Africa. Oromin’s management team consists of experienced industry professionals with a track record of discoveries. Oromin Explorations has their corporate headquarters in Vancouver, British Columbia.
The OJVG Gold Project is an advanced stage, low risk construction-ready project with several options for development and further resource enhancement. The Project is in Eastern Senegal, 650 km east of the capital city of Dakar. It is within an emerging West African gold-mining district similar to producing gold camps across the border in nearby Mali.
A 15-year renewable mining license was granted by the Government of Senegal in January of 2010. A positive feasibility study was completed in mid 2010 by SRK. This was followed by significant project enhancements. These included a positive preliminary economic assessment of heap leach potential and a resource update announced in May 2011; subsequent expansion of various deposits; and the announcement of new gold discoveries outlined by continued drilling through to December 2011.
In August, Oromin Explorations Ltd, on behalf of Oromin Joint Venture Group Ltd. (OJVG), reported that the Mineral Resource estimate and the Reserve and Feasibility Study Update announced on May 29, 2012 remain on schedule. The expectation is that the Mineral Resource estimate will be completed by early September and the Reserve and Feasibility update is expected in November. Furthermore, Oromin is continuing to work with their OJVG partners to assess development, financing, and strategic alternatives towards maximizing project value. This includes discussions with various parties that could lead to a potential acquisition of Oromin.
The Company believes that the post feasibility study work by OJVG will add substantial project value through increases in open pit and underground mining potential and an extended mine life. In view of that, OJVG has initiated the current update for the feasibility study to take into account all 2010 and 2011 drilling completed after the January 2010 data cut-off date used for the original 2010 study. In addition, the final approval from the Government of Senegal for the project's Environmental and Social Impact Assessment (ESIA) was received on May 29, 2012.
Oromin Explorations Ltd. (OLEPF), closed on Thursday at $0.7180, up 6.85%, on 238,221 volume with 7 trades. The average volume for the last 60 days is 12,737 and the stock's 52-week low/high is $0.43/$1.2396.
Applied Minerals, Inc. (AMNL)
Real Pennies reported earlier on Applied Minerals, Inc. (AMNL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 1924, Applied Minerals, Inc. is the leading producer of Halloysite Clay solutions from their wholly-owned Dragon Mine property in Utah. Halloysite is an aluminosilicate clay that forms naturally occurring nanotubes. The Company was formerly known as Atlas Mining Co. They changed their name to Applied Minerals, Inc. in October of 2009. Applied Minerals shares trade on the OTCQB; the Company has their headquarters in New York, New York.
Applied Minerals serves the traditional halloysite markets for use in technical ceramics and catalytic applications. Additionally, the Company has developed niche applications that benefit from the tubular morphology of their halloysite. These applications include carriers of active ingredients in paints, coatings and building materials, environmental remediation, agricultural applications, and high-performance additives and fillers for plastic composites.
The Company holds a 100 percent interest in the Dragon Mine, a halloysite clay property covering an area of approximately 230 acres located in the Tintic District of Utah. The Dragon Mine is the only known measured resource of Halloysite Clay in the western hemisphere significant enough for large scale commercial production. The Dragon Mine also contains an iron resource consisting of Goethite, Hematite, as well as an amorphous iron phase identified as Ferrihydrite.
Applied Minerals markets their portfolio of halloysite clay solutions under the Dragonite trademark. They also have investments in the characterization of the Dragon iron ore resource, marketed for use in pigments and technical applications, such as smoke suppression and remediation of arsenic and metal contamination. The Company also holds an extensive portfolio of intellectual property surrounding the technology related to their material.
This past June, Applied Minerals announced the appointment of Professor Roger Rothon to the Company's newly created Technical Advisory Board. Prof. Rothon is a recognized expert in the field of particulate fillers and flame retardants. He has a 40 year record of accomplishment developing commercial materials, products, and processes. His tenure at Imperial Chemical Industries (ICI), acquired by Akzo Nobel N.V., led to innovative new filler products and coupling agents; subsequent endeavors have resulted in a broad array of high-tech and eco-friendly products.
Applied Minerals, Inc. (AMNL), closed on Thursday at $1.31, unchanged, on 46,546 volume with 21 trades. The average volume for the last 60 days is 22,423 and the stock's 52-week low/high is $0.999/$1.94.
DynaVox, Inc. (DVOX)
CRWEPicks, CRWEFinance, DrStockPick, PennyOmega, PennyToBuck, CRWEWallStreet, BestOtc, StockHotTips, and Dynamic Wealth Report reported previously on DynaVox, Inc. (DVOX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
DynaVox, Inc. is the world's leading provider of communication and education products for individuals with significant speech, language and learning disabilities. DynaVox is a holding company whose primary operating entities are DynaVox Systems, LLC and Mayer-Johnson, LLC. The Company’s mission is to enable their customers to realize their full communication and education potential by developing industry-leading devices, software, and content and by providing the services to support them. DynaVox has their headquarters in Pittsburgh, Pennsylvania, and the Company lists on the NASDAQ Global Select market.
DynaVox is the leading provider of speech generating devices and symbol-adapted special education software. The design of these solutions are to help individuals, who have complex communication and learning needs, participate in the home, classroom, and community. The Company assists individuals, families, and professionals with an extensive field support organization, as well as centralized technical and reimbursement support.
DynaVox’s Boardmaker line of special education software is used as a publishing and editing tool to create interactive, symbol-based educational activities and materials for special education students. This software is also used to adapt text-based materials to symbol-based materials for students with limited reading skills. The Company’s proprietary Picture Communication Symbols (PCS®) are used in their Boardmaker software line and their DynaVox line of speech generating devices.
DynaVox set a new standard for handheld speech solutions with the introduction of the DynaVox Xpress in August of 2009. It combines comprehensive AAC tools with a variety of mainstream communication features. The Xpress delivers powerful communication capabilities for individuals living with the effects of stroke, autism, Down syndrome, traumatic brain injury, aphasia, ALS and apraxia of speech.
Today, DynaVox announced that they will announce results for the fourth quarter and fiscal year ended June 29, 2012 on Thursday, September 20, 2012, after market close. The Company will host a conference call to discuss these results with additional comments and details. The conference call is scheduled to start at 4:30 p.m. EDT on September 20, 2012.
DynaVox, Inc. (DVOX), closed on Thursday at $0.88, up 1.15%, on 633,228 volume with 354 trades. The average volume for the last 60 days is 68,825 and the stock's 52-week low/high is $0.7602/$6.05.
Positron Corp. (POSC)
PennyTrader Publisher reported recently on Positron Corp. (POSC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTC Bulletin Board, Positron Corp. is a company that provides a comprehensive “full nuclear cardiology solution”. The Company is a leading molecular imaging healthcare enterprise. They vertically integrate all the segments of nuclear cardiology—providing an end-to-end solution for cardiac Positron Emission Tomography (PET). By way of proprietary PET imaging systems and radiopharmaceutical solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes while practicing cost effective medicine. In January 2012, Positron acquired Manhattan Isotope Technology, LLC.
Positron offers a range of products and services for the nuclear imaging community. Their Attrius is the only Food and Drug Administration (FDA) approved dedicated PET scanner optimized for cardiac imaging. Attrius was named the "Most Innovative Device of 2010" by the renowned business research and consulting firm Frost & Sullivan.
The Company offers a comprehensive and premier clinical, technical, and service customer care plan, via their PosiStar customer care services. PosiStar includes 24/7 clinical and service support; uptime guarantees; remote access diagnostic/maintenance; physician interpretation training; billing training; nurse training; post-install physician over-reads; ICANL approval assistance; 6 months evaluation/assessment; industry luminary collaboration, and more.
Additionally, Poistron’s PosiRx is a system that automates the elution, preparation, and dispensing processes for radiopharmaceutical agents used in SPECT molecular imaging with Tc-99m. PosiRx eliminates the need for scheduled deliveries of unit doses from centralized radiopharmacies.
Today, Positron announced that Jubilant DraxImage, Inc. (JDI), a Jubilant Life Sciences Company, and Positron executed a Letter of Intent (LOI) pertaining to Positron's supply of Active Pharmaceutical Ingredient (API) grade Sr-82 for the JDI Sr-82/Rb-82 generator; JDI's and Positron's co-promotion of JDI Sr-82/Rb-82 generators to end-users (upon FDA clearance); and Positron's lifecycle management for expired JDI Sr-82/Rb-82 generators. Positron believes that the strategic alliance between JDI and Positron will facilitate the stabilization, security, and growth of the industry by increasing the supply of radioisotopes and radiopharmaceuticals.
Positron Corp. (POSC), closed on Thursday at $0.0095, even for the day, on 595,480 volume with 20 trades. The average volume for the last 60 days is 1,346,289 and the stock's 52-week low/high is $0.005/$0.029.
Prophecy Coal Corp. (PRPCF)
Streetwise Reports reported recently on Prophecy Coal Corp. (PRPCF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Prophecy Coal Corp. engages in developing energy projects in Mongolia. Their wholly-owned subsidiary, Prophecy Power, is advancing plans for a proposed 600 MW mine-mouth power plant, which has been permitted by the Mongolian government, adjacent to the Company’s Chandgana coal deposit. Negotiations on financing, power purchase agreement, and construction management are underway. Prophecy Coal lists on the OTCQX International. The Company has their head office in Vancouver, British Columbia and a regional office in UlaanBaatar, Mongolia.
Substantially all of Prophecy Coal’s resources are not mineral reserves; therefore they do not have demonstrated economic viability. The Chandgana coal project includes three coal licenses with a measured and indicated coal resource of 1.2 billion tonnes. In the initial phase, the coal for the power plant will be sourced from two mining licenses containing a measured and indicated resource of 131 million tonnes with a strip ratio of 0.5:1 and a starter pit. An NI 43-101 Preliminary Economic Assessment study is taking place in connection with the coal project.
In June 2012, Prophecy Coal consolidated the Chandgana coal basin by agreeing to acquire the Tugalgatai licenses from Tethys Mining, LLC. Last month, Prophecy Coal unveiled their subsidiary, Prophecy Power Generation, LLC, a wholly-owned Mongolian subsidiary focusing on the power sector in Mongolia. Prophecy Power Generation, formerly known as Eastern Energy Development, LLC, was incorporated in 2010 with the specific business objective of supplying power to Mongolia via the construction of the Chandgana Thermal Power Plant. Prophecy Coal’s Chandgana, LLC in parallel will develop the Chandgana coal project to ensure fuel supply to Prophecy Power.
Today, Prophecy Coal announced that Prophecy Power Generation formally submitted their Power Purchase Agreement (PPA) proposal to the Mongolian government. The proposed PPA details the terms under which Prophecy Power would be prepared to supply power to Mongolia's National Transmission Grid Co.
Prophecy Power has Mongolia's aforementioned leading 600MW mine-mouth, thermal power plant project, with a construction license awarded by the Mongolian government in late 2011. Prophecy Power sources coal from the Chandgana coal project, held by Prophecy's wholly owned Chandgana Coal. The PPA will be the cornerstone to attract and finalize Joint Venture (JV) power plant developer interest, and solidify project financing. Prophecy expects to receive a formal reply within 90 days.
Prophecy Coal Corp. (PRPCF), closed on Thursday at $0.171, down 0.58%, on 886,400 volume with 29 trades. The average volume for the last 60 days is 67,975 and the stock's 52-week low/high is $0.16/$0.746.
China Gengsheng Minerals, Inc. (CHGS)
SmarTrend Newsletters, Stockhouse, ChartPoppers, Top Secret Stocks, and Sling-Shot-Stocks reported earlier on China Gengsheng Minerals, Inc. (CHGS), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Listed on the NYSE Amex, China GengSheng Minerals, Inc. is a leading high-tech industrial materials manufacturer. They manufacture heat-resistant, energy-efficient materials for an assortment of industrial applications. The Company develops, manufactures, and markets an extensive range of high-tech industrial material products. These include monolithic refractories, industrial ceramics, fracture proppants, as well as fine precision abrasives. Founded in 1986, China Gengsheng Minerals is based in Gongyi, Henan, China.
The Company sells their products primarily to the iron and steel industry as heat-resistant components for steel-making furnaces, industrial kilns, and other high-temperature vessels. This is to guarantee and improve the productivity of those expensive pieces of equipment, while reducing their consumption of energy. The Company currently has over 170 customers in the iron, steel, oil, glass, cement, aluminum, and chemical businesses located in China and other nations.
China Gengsheng Minerals conducts their business by way of GengSheng International Corp., a British Virgin Islands company, and their Chinese subsidiaries, which are Henan GengSheng Refractories Co., Ltd., Zhengzhou Duesail Fracture Proppant Co., Ltd., Henan GengSheng Micronized Powder Materials Co., Ltd, Guizhou SouthEast Prefecture Co., Ltd., GengSheng New Materials Co., Ltd, Henan GengSheng High Temperature Materials Co., Ltd. and Henan Yuxing Proppant Co., Ltd.
Last month, China GengSheng Minerals announced their financial results for the second quarter ended June 30, 2012. Revenue decreased 4.0 percent year-over-year to approximately $19.6 million. Refractories sales were approximately $11.6 million, compared with approximately $12.5 million in the second quarter of 2011.
Fine precision abrasives product sales were approximately $3.3 million, compared with approximately $1.5 million in the second quarter of 2011. Fracture proppant sales were approximately $4.2 million, compared with approximately $5.9 million in the second quarter of 2011.
Gross profit was approximately $3.1 million, or 15.6 percent of total sales. This is in comparison with approximately $5.3 million or 26.1 percent of total sales in the same period a year prior. Net loss attributable to the Company was approximately $3.8 million, or $0.14 per share. This is in comparison with a net loss of approximately $247,000, or $0.01 per share in the second quarter of 2011.
China Gengsheng Minerals, Inc. (CHGS), closed on Thursday at $0.37, down 2.63%, on 37,800 volume with 34 trades. The The average volume for the last 60 days is 21,369 and the stock's 52-week low/high is $0.342/$1.48.
Cardero Resource Corp. (CDY)
Michael Pound, Wyatt Investment Research, and The Street reported earlier on Cardero Resource Corp. (CDY), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Founded in 1999, Cardero Resource Corp. focuses on coal and iron ore. The Company's two primary properties include Carbon Creek (metallurgical coal) and Sheini Hills (iron ore). Cardero works to identify early, then acquire world-class bulk commodity deposits and advance them to production in prospective, under-explored regions of the world. Cardero Resource has their corporate headquarters in Vancouver, British Columbia (BC).
The Company's Carbon Creek property is in the Peace River Coal Fields in northern BC. At present, Carbon Creek has an estimated NI 43-101 resource of 166Mt M&I and 167Mt Inferred of metallurgical coal from which Cardero Resource plans to produce a hard coking coal, a semi-soft coking coal, as well as a PCI product. The Company’s intention is to continue with exploration drilling aimed at expanding the current resource base and advancing the Carbon Creek asset towards a production decision.
The Sheini Hills Iron Project is a large-scale iron project in Ghana. It is made up of three prospecting licenses covering the Sheini Hills iron ore deposit (approximately 400 square kilometers in aggregate), which is in line with the Company's bulk commodity focus. The Sheini Hills Iron formation has an indicated average thickness of 50 to 150 meters and can be followed by surface mapping and sampling for a minimum of 30 kilometers of strike.
The Company also holds an option to acquire up to an 85 percent interest in the Longnose property (Iron & Titanium). They also hold a 100 percent leasehold interest in the Titac property under a mining lease dated July 1, 2009. The Longnose and Titac properties are located in northeastern Minnesota in St. Louis County.
This week, Cardero Resource announced the appointment of Mr. David Thompson as Resource Manager for Cardero Coal, Ltd. (a wholly owned subsidiary of Cardero). In addition, the Company provided an update on the Prefeasibility Study and 2012 exploration program at the Company's flagship Carbon Creek metallurgical coal deposit. The current work at Carbon Creek is concentrating on an intended Q3 announcement of results from a Prefeasibility Study (PFS) and filing of the NI43-101 Technical Report within 45 days thereafter (early Q4).
Yesterday, Cardero Resource announced the latest high-grade iron intersections at the Sheini Hills Iron Project in Ghana. Highlights include Hole 55: 89.7 meters from surface, grading 46.2 percent Iron; Hole 45: 63.0 meters from surface, grading 42.6 percent Iron; Hole 57: 30.5 meters from surface, grading 44.0 percent Iron; Hole 51: 45.0 meters from surface, grading 40.1 percent Iron; Hole 40: 50.4 meters from surface, grading 40.2 percent Iron; Hole 52: 43.7 meters from surface, grading 40.1 percent Iron; and Hole 48: 66.0 meters from surface, grading 41.6 percent Iron.
Cardero Resource Corp. (CDY), closed on Thursday at $0.76, down 2.56%, on 11,700 volume with 29 trades. The average volume for the last 60 days is 47,969 and the stock's 52-week low/high is $0.65/$1.56.
Mercator Minerals Ltd. (ML.TO)
Wealth Daily reported previously on Mercator Minerals Ltd. (ML.TO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Mercator Minerals Ltd. is a copper, molybdenum, and silver producer. The Company has a diversified portfolio of high quality assets in the U.S. and Mexico. Mercator has operations in the safe mining friendly jurisdictions of Arizona and Sonora, Mexico. The Company is based in Vancouver, British Columbia, and their shares trade on the Toronto Stock Exchange.
Mercator Minerals owns 100 percent of the producing Mineral Park Mine. This mine is in Kingman in northwestern Arizona, approximately 120 kilometers southeast of Las Vegas, Nevada. The mine has a 23-year life (as at January 2011). This calendar year, the projection is that it will produce 42.6 million pounds of copper, 10.0 million pounds of molybdenum and over 546,000 ounces of silver. The 2012 mine plan at the Mineral Park mine includes mining through the transition from supergene enriched copper material into primary hypogene copper mineralization.
In addition, Mercator owns 100 percent of the El Pilar copper deposit. This deposit is in the State of Sonora, Mexico, approximately 15 kilometers south of the Arizona/Mexico border. The El Pilar property is in a highly prospective belt of porphyry copper deposits ranging from La Caridad in the south through to central Arizona in the north. The El Pilar copper project is well advanced and has obtained all the permits required to begin construction.
Furthermore, the Company owns 100 percent of the El Creston molybdenum-copper deposit. This deposit is in the State of Sonora, Mexico, approximately 175 kilometers south of the U.S. Border, 145 kilometers northeast of the city of Hermosillo. Mercator expects to file an updated NI 43-101 technical report on El Creston in the second half of this year, after which a decision on the development timetable for the El Creston project may be made.
Concerning their other projects, Mercator maintains a 100 percent interest in the Molybrook molybdenum property located on the south coast of Newfoundland. Moreover, the Company has a 100 percent interest in the 11,718 hectare Ajax Molybdenum Property located 13 km north of Alice Arm, British Columbia.
This week, Mercator Minerals announced the results of an updated feasibility study (2012 FS) to the feasibility study completed November 2011 (2011 FS), which further enhances the potential development of a strong, large-scale, low-cost copper mine at the El Pilar project. The estimated Net Present Value (NPV) increases by 24 percent to US$417 million from the 2011 study.
The 2012 FS includes a new base case that utilizes enhanced copper recoveries based on heap leaching in three meter lift heights, instead of the six meter lift heights used in the 2011 FS. Using the same copper price assumptions as the November 2011 FS, the 2012 FS updates the Project's mineral reserve, metal recoveries and mine plan to determine the Project's revised economics.
Mercator Minerals Ltd. (ML.TO), closed on Thursday at $0.43, down 3.37%, on 1,376,560 volume. The stock's 52-week low/high is $0.42/$2.70.
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $1.25, even with yesterday's close, on 198,982 volume with 160 trades. The stock’s average daily volume over the past 60 days is 4,647, and its 52-week low/high is $0.85/$10.01.
TNI BioTech, Inc. announced the appointment of Dr. Ronald Herberman to the positions of Senior VP of R&D and Chief Medical Officer today, where he will bring his vast experience from across the entire spectrum of drug development/portfolio management directly to bear on the company's global development, clinical research, and medical initiatives.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical Officer
TNI BioTech, Inc. Acquires Portfolio of Exclusive Licenses to the Portfolio of Patents of Dr. Bernard Bihari
TNI BioTech, Inc., in Partnership With GB Oncology and Imaging Group LTD., Signs Agreement With the Republic of Malawi
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.40, up 6.29%, on 4,100 volume with 7 trades. The stock’s average daily volume over the past 60 days is 7,460, and its 52-week low/high is $1.10/$4.00.
Duma Energy Corp. reported completion of the share exchange agreement with Namibia Exploration, Inc. today, making NEI a wholly-owned subsidiary of Duma and bringing into the company’s portfolio a 39% working interest on a choice 5.3M-acre piece of highly prospective oil and gas land in Namibia, for which the exploration license is already approved by the Namibian Government.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Receives Approval From Government of Namibia for Exploration License Issued for 5.3 Million-Acre Concession
Duma Energy Acquires Interest in 5.3 Million-Acre African Concession
Duma Energy Enters Final Stage of Negotiations for African Concession
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.24, up 2.13%, on 109,893 volume with 34 trades. The stock’s average daily volume over the past 60 days is 56,567, and its 52-week low/high is $0.21/$0.97.
International Stem Cell Corp. reported entry by the company’s cosmoseutical subsidiary, Lifeline Skin Care, into an agreement that will see its advanced anti-aging skin care products distributed in China to a roughly $8B per year cosmetic market via the extended clinical network of top Chinese pharma company, Sinopharm Group.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Entry Into Chinese Market
International Stem Cell Corp to Participate in Upcoming Investor Conferences
International Stem Cell Corp to Present at the Southern California Investor Conference on August 30, 2012
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.80, on 2,940 volume with 2 trades. The stock’s average daily volume over the past 60 days is 5,205, and its 52-week low/high is $0.61/$1.87.
GlobalWise Investments, Inc. announced the successful completion of multiple training programs designed around the company's cloud-based Enterprise Content Management software and its various applications. Bringing key Channel Partners up to speed on the latest developments to its sophisticated yet intuitive ECM software platform is something the company takes seriously enough that it provides such sessions twice every month.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Channel Partner Training Programs Provide Growth Accelerator
GlobalWise Announces New Channel Sales Partnership With RJ Young
GlobalWise Accepted as Member of Prestigious Organization Technology United
TNI BioTech, a biotech company focused on combating fatal diseases through the activation and mobilization of the body’s immune system, announced that effective immediately Dr. Ronald Herberman has joined the management team as Senior Vice President of Research and Development and Chief Medical Officer. Dr. Herberman’s will be responsible for leading the company’s global development, clinical research, and medical initiatives.
Dr. Herberman brings extensive experience in all phases of drug development and drug portfolio management — including acquisition of new assets, and in dealing with regulators and government agencies. Previously, he held the position of Chief Medical Officer at Intrexon Corporation where he was responsible for scientists and clinicians in discovery, clinical research and development, regulatory affairs, and medical affairs. He was also the founding director of the University of Pittsburgh Cancer Institute and Associate Vice Chancellor for Cancer Research, Hillman Professor of Oncology, and Professor of Medicine at the University of Pittsburgh School of Medicine.
An internationally recognized tumor immunologist, Dr. Herberman has made major discoveries in his field and has fostered the application of this information to novel approaches to cancer therapy, diagnosis, and prevention. Dr. Herberman has received numerous awards, including the Lifetime Science Award from the Institute for Advanced Studies in Immunology and Aging. The significance of Dr. Herberman’s foundational scientific discoveries is accentuated by his recognition as one of the 100 most-cited research authors during the 1980s.
Dr. Nicholas Plotnikoff, TNI BioTech, Inc. Chairman, stated, “In order to successfully become a world-class leader, we need significant expertise in clinical, regulatory and leadership development, along with a deep knowledge of immunology and Dr. Herberman brings demonstrated strengths in these areas having made major discoveries in his field and has fostered the application of this information to novel approaches to cancer therapy, diagnosis and prevention during his time as a leader at the National Cancer Institute and Founding Director of the University of Pittsburgh Cancer Institute.”
“During his career, Dr. Herberman has been recognized as a leader in the field of immunology,” Dr. Plotnikoff continued. “The phenomenon of natural killer (NK) cell-mediated cytotoxicity against tumors was first discovered in Dr. Herberman’s laboratory at the National Cancer Institute in the early 1970s. In addition to his pioneering investigation of NK cells, Dr. Herberman has played a leading role in multiple areas of tumor immunology. TNI BioTech therapies and treatments draw upon the theory that medicine can enlist the body’s own immune system to combat cancer and autoimmune diseases that are Dr. Herberman’s specialty. His experience and strategic perspective precisely meet TNI BioTech’s needs today.”
Dr. Herberman commented, “I am very excited to assume a leadership position in TNI Biotech Inc. I have had the privilege to know Dr. Plotnikoff for about 30 Years and I have been very impressed with his pioneering studies of the effects of opioid peptides on the immune system. I am convinced that TNI Biotech’s drugs have much potential for the treatment of not only cancer, but also a range of other diseases including multiple sclerosis, HIV/AIDS, and Crohn’s Disease. I intend to rapidly build on a pre-existing foundation of clinical research with low dose naltrexone and met-enkephalin, and develop innovative approaches to use them to stimulate the immune system to make an impact on these and other chronic diseases.”
To learn more about the company and its immunotherapy technologies, visit www.tnibiotech.com
Today before the opening bell, Duma Energy announced the completion of the share exchange agreement, dated August 7, 2012, with Namibia Exploration, Inc. (“NEI”); the “Acquisition.” NEI is now a wholly owned subsidiary of Duma.
Through NEI, Duma has received a 39% working interest (43.33% cost responsibility) in an onshore African petroleum concession located in the Republic of Namibia which is approximately 5.3 million acres in size covered by Petroleum Exploration License No. 0038 issued by the Republic of Namibia Ministry of Mines and Energy. The company holds its indirect working interest in the concession in partnership with the National Petroleum Corporation of Namibia Ltd. (“NPC Namibia”) and Hydrocarb Namibia Energy Corporation, a majority owned subsidiary of Hydrocarb Corporation.
“The timely issuance of the concession license by the government of Namibia allows us now to begin focusing our efforts on the task of exploring our massive concession, which is roughly the size of the state of Massachusetts,” stated Jeremy G. Driver, Chairman and CEO of Duma Energy Corp. Driver added, “We are excited to move forward with the exploration phase in Namibia and are encouraged by the geological progress and findings so far.”
Pasquale Scaturro, Hydrocarb’s President and Chief Operating Officer, added, “There are few governments in Africa that can match the transparency and professionalism of Namibia. We are truly pleased to have such a large and premium concession located in an extremely prospective basin.”
Duma also told investors that it has entered into a Consulting Services Agreement with Hydrocarb whereby Hydrocarb will provide various consulting services with respect to Duma’s business ventures in Namibia. Those who wish to review further information regarding the acquisition, the consulting agreement, or the concession in Namibia should visit the company’s website at www.duma.com or view the company’s recent SEC filings.
For additional information on Duma Energy, visit the company’s website at www.DUMA.com
International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today announced its cosmoseutical subsidiary Lifeline Skin Care (www.lifelineskincare.com) has signed an agreement to distribute its anti-aging skin care products in China using the extended clinical network of one of the largest pharmaceutical companies in China, Sinopharm Group.
Lifeline engages in the development, manufacturing, and commercialization of advanced skin care products based on growth factors and peptides derived from human parthenogenetic stem cells. The products, developed by ISCO’s scientific team in collaboration with renowned skin care experts, deliver anti-aging benefits, resulting in younger-looking skin. The products are available for purchase through medical offices and luxury spas across the United States and from www.lifelineskincare.com.
Annual sales of cosmetic products in mainland China are estimated at $8 billion. The large population of affluent consumers and surging demand for consumer products provide ISCO with solid opportunity. Now growing at an annual rate of over 10%, the Chinese market is an ideal choice for further growth. Together with its Chinese partner Brilliant Sunrise SBC, which is responsible for importation and regulatory approvals, Lifeline will offer its breakthrough anti-aging skin care products in China’s largest and most respected hospitals, spas, and through online channels.
“We’re excited to partner with the Lifeline Skin Care brand of science-based skin care and to bring their cutting edge technology to China. Lifeline is a leader in an emerging field that will change how serious cosmetic brands approach skin care. By rolling out the products in channels such as Shanghai’s 9th People Hospital and Hua Shan Hospital, which have some of the best cosmetic surgery and skin care centers in China, we aim to introduce the product in a way that highlights Lifeline Skin Care’s unique value proposition,” stated Nicole Sha, Co-founder of Brilliant Sunrise SBC.
“We are extremely pleased that we can now offer our stem cell-based anti-aging skin care products in China. By using this network of healthcare centers and spas, we are making our unique products available to consumers through a credible provider that they already trust and have a relationship with,” added Donna Queen, President of Lifeline Skin Care.
For additional information on ISCO, visit the company’s website at www.InternationalStemCell.com
GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems, today announced that it has completed multiple training programs that educate new Channel Partners on the use of its cloud-based ECM software and various applications.
Once trained, Channel Partners can immediately begin to market, sell, and install the GlobalWise ECM cloud-based portfolio. The Channel Program implemented by management has dramatically increased the sales volume for GlobalWise by utilizing proven sales professionals with existing clients in the company’s target markets. This strategy places the Channel Partners in the lead role to increase demand for their own products by finding new markets for the ECM software and enables GlobalWise to focus on demand fulfillment and client satisfaction.
“We have trained all eight new Channel Partners signed in 2012, including some of the largest in the copier and printer industry, over the last few months,” stated William J. “BJ” Santiago, CEO of GlobalWise. “By teaming up with recognized industry leaders as Channel Partners, it has allowed us to secure multiple new clients. The engineers and sales teams at MWAi and RJ Young have all commented on how easy the Intellivue™ software is to install and configure compared to other products they have worked with. By enabling new revenue sources, like the ‘Per Click Charge’ service to scan, archive, index and inventory documents directly from the multi-function printer, we give them value-added services in addition to the traditional per page charged for color or black and white copies. Plus, we do this in a simple, all-inclusive pricing model that is easy to understand and sell.”
“We expect our strategic Channel Partnerships to grow in the coming months and expect to continue our growth into 2013 and beyond,” added Mr. Santiago. “We see these accelerated partner on-boarding efforts and training sessions as two key elements to our success: 1) a true commitment from our partners to quickly roll-out the Intellivue™ cloud-based solution to their respective industries and clients and 2) a continued direct correlation of our revenue growth and success in the second quarter from existing partners who have already gone through the same training. GlobalWise is well positioned to take advantage of this growth and our team is ready to manage the new client opportunities.”
The GlobalWise Channel Partner training program has two components: Intellivue™ Certified Professional (ICP) and Intellivue™ Certified Engineer (ICE) programs. The ICP training program is geared primarily towards marketing and sales professionals in the roles of discovery, design, development, training, and support of Intellivue™ electronic document management platform solutions at a departmental or enterprise level. The ICE training program is geared towards operational support and engineering professionals with the technical skills to install, configure, operate, and troubleshoot the Intellivue™ software platform in a Microsoft SQL and Microsoft Windows Server environment.
For more information, visit www.GlobalWiseInvestments.com
Today's Top 3
Research Driven Alerts
The QualityStocks Public Company Sponsor News